Optimi Health

Optimi Health FCF/Debt

The Free Cash Flow to Debt Ratio of Optimi Health (OPTI.CN) as of Nov 1, 2026 is -252.15 %. In the previous year, Free Cash Flow to Debt Ratio was -269.01 % — a change of -6.27% (higher).

FCF/Debt

-252.15 %

YoY

-6.27%

Last updated:

Free Cash Flow to Debt Ratio of Optimi Health is 2024 -252.15 % . Free Cash Flow to Debt Ratio of Optimi Health was 2023 -269.01 % . It decreases by -6.27% higher compared to the previous year.

The Optimi Health FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2023
-269.01 CAD
Jan 1, 2024
-252.15 CAD
The Optimi Health FCF/Debt history
YEARFCF/DebtYoY
-252.15 %-6.27%
-269.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Optimi Health Stock analysis

What does Optimi Health do? Optimi Health Corp develops, cultivates, extracts, processes, and distributes functional mushrooms and psychedelic substances. The company produces licensed drug and nutraceutical products including natural and synthetically formulated GMP-grade psilocybin, psilocin, MDMA, and other psychedelic substances under Health Canada regulations. Optimi supplies health food distributors, drug developers, and patients through its manufacturing facilities. The firm operates as a supplier of drug and nutraceutical products serving domestic and international health and wellness markets. Optimi Health Corp owns approximately 20,000 technologically advanced manufacturing, cultivation, and analytical facilities. These facilities support the production of functional mushrooms and psychedelic substances for health food distributors, drug developers, and patients. The company focuses on supplying synthetic and natural psychedelics to the international market while adhering to Health Canada's drug manufacturing and formulation standards. The firm's product portfolio includes GMP-grade psilocybin, psilocin, MDMA, and functional mushrooms, targeting health food distributors, drug developers, and patients. Optimi operates as a supplier of drug and nutraceutical products, serving both domestic and international health and wellness markets. Its manufacturing capabilities enable the production of natural and synthetically formulated psychedelic substances under Health Canada's regulatory framework. Optimi Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optimi Health stock

Free Cash Flow to Debt Ratio of Optimi Health is -252.15 % in 2024.

Free Cash Flow to Debt Ratio of Optimi Health changed from -269.01 % to -252.15 %, representing a -6.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Optimi Health since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Optimi Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Optimi Health

All Key Metrics — Optimi Health